intracellular
event
synthesi
glycosyl
transport
lymphocyt
choriomening
viru
lcmv
glycoprotein
examin
shown
nglycanas
digest
lcmv
strain
bear
five
oligosaccharid
two
pulsechas
label
experi
presenc
drug
inhibit
nlink
oligosaccharid
addit
process
demonstr
addit
high
mannos
precursor
oligosaccharid
necessari
transport
cleavag
viral
gpc
glycoprotein
moreov
presenc
tunicamycin
inhibit
en
bloc
addit
mannoserich
side
chain
viru
bud
substanti
decreas
infecti
virion
reduc
looofold
supernat
medium
incub
presenc
castantospermin
permit
addit
oligomannosylrich
chain
block
process
restor
transport
cleavag
gpc
matur
virion
final
temperatur
block
experi
determin
matur
gpc
oligosaccharid
endoglycosidas
h
resist
form
preced
cleavag
latter
process
like
occur
golgi
postgolgi
compart
iw
present
address
lymphocyt
choriomening
viru
lcmv
prototyp
member
arenavirida
provid
investig
wealth
inform
virushost
interact
mous
lcmv
establish
rang
diseas
acut
lethal
choriomening
lifelong
persist
infect
studi
diseas
sever
fundament
concept
evolv
includ
toler
immun
complex
diseas
review
buchmeier
et
al
viru
alter
special
luxuri
function
differenti
cell
oldston
et
klavinski
et
requir
major
histocompat
complex
express
antivir
cytotox
tcell
kill
viru
clearanc
zinkernagel
doherti
zinkernagel
welsh
structur
lcmv
best
character
arenavirus
three
major
structur
protein
nucleocapsid
protein
np
kda
two
glycoprotein
ai
kda
nl
kda
addit
least
two
quantit
minor
protein
l
kda
presum
viral
rna
depend
rna
polymeras
minor
polypeptid
term
z
may
constitut
zinc
bind
protein
glycoprotein
posttransl
cleav
cellassoci
mannoserich
precursor
gpc
nr
kda
buchmeier
oldston
work
date
focus
antigen
structur
glycoprotein
major
glycoprotein
least
four
bcell
epitop
two
bind
neutral
antibodi
three
overlap
epitop
parekh
buchmeier
two
conserv
among
arenavirus
weber
buchmeier
buchmeieret
littl
known
posttransl
process
arenaviru
glycoprotein
proteolyt
cleavag
site
gpc
appar
pair
basic
amino
acid
sequenc
argarg
amino
acid
cleavag
mediat
cellular
proteas
similar
precursor
glycopeptid
also
identifi
pichind
harnish
et
lassa
clegg
lloyd
tacarib
virus
gimenez
eta
franzfernandez
et
howev
tacarib
contain
one
structur
glycoprotein
understand
biosynthesi
process
transport
lcmv
glycoprotein
may
aid
interpret
aspect
viral
biolog
exampl
persist
lcmv
infect
select
modul
glycoprotein
express
report
infect
cell
welsh
buchmeier
tissu
oldston
buchmeier
mechan
regul
remain
unclear
moreov
recent
studi
describ
cytotox
tcell
epitop
glycoprotein
lcmv
whitton
et
base
current
knowledg
role
class
mhc
endogen
pathway
antigen
present
like
associ
class
glycoprotein
fragment
deriv
occur
within
intracellular
transport
pathway
final
littl
known
interact
lcmv
glycoprotein
cellsurfac
viral
receptor
mechan
viral
entri
cell
studi
report
address
two
basic
aspect
posttransl
process
lcmv
nlink
glycosyl
glycoprotein
requir
kinet
subsequ
transport
trim
proteolyt
cleavag
gpc
viru
use
throughout
experi
lcmv
armstrong
clone
plaqu
purifi
stock
armstrong
parekh
buchmeier
wright
et
work
stock
prepar
infect
cell
multipl
infect
moi
harvest
supernat
hr
later
viru
purifi
polyethylen
glycol
precipit
follow
band
vv
squibb
diagnost
gradient
buchmeier
oldston
tunicamycin
tun
deoxymannojirimycin
dmj
swainsonin
ssn
purchas
boehringermannheim
castanospermin
csp
vmethyldeoxynojirimycin
nmdnj
genzym
stock
solut
tun
prepar
dmso
stock
solut
dmj
ssn
nmdnj
prepar
cultur
medium
immunofluoresc
experi
inhibitor
ad
time
infect
maintain
durat
metabol
label
inhibitor
ad
infect
cultur
hr
label
retain
throughout
label
chase
period
optim
drug
concentr
use
predetermin
titrat
inhibitori
activ
cell
concentr
use
tun
pgml
csp
pgml
nmdnj
mm
dmj
mm
ssn
pgml
control
cultur
tun
incub
presenc
equival
concentr
dmso
lmmunofluoresc
indirect
immunofluoresc
permeabil
cell
done
cell
coverslip
infect
hr
earlier
moi
buchmeier
et
surfac
immunofluoresc
infect
bhk
cell
trypsin
stain
antilcmv
monoclon
antibodi
mab
fluoresceinlabel
sheep
antimous
igg
studi
establish
lcmv
antigen
surfac
infect
cell
resist
trypsin
treatment
buchmeier
et
al
lmmunoprecipit
polyactylamid
gel
electrophoresi
page
cell
infect
moi
hr
puls
label
hr
methioninefre
dulbecco
medium
flow
laboratori
contain
iml
l
methionin
amersham
cell
pretreat
hrwith
glycosyl
inhibitor
indic
concentr
methioninefre
media
label
cell
chase
indic
medium
contain
glycosyl
inhibitor
iofold
excess
cold
lmethionin
lysat
prepar
buffer
contain
mm
tri
mhl
naci
mm
caci
mm
mgci
vv
vv
glycerol
vv
aprotinin
clear
centrifug
rpm
min
cell
equival
control
test
lysat
incub
antibodi
final
dilut
min
wash
protein
asepharos
bead
sigma
ad
tube
incub
min
continu
shake
precipit
collect
centrifug
wash
three
time
wash
buffer
mll
tri
mm
lici
resuspend
buffer
contain
sd
endoglycosidas
h
eh
digest
done
immuneprecipit
viral
protein
briefli
precipit
sampl
digest
hr
unit
eh
sampl
heat
min
load
onto
polyacrylamid
gel
laemmli
protein
marker
amersham
run
gel
electrophoresi
gel
fix
acet
acid
methanol
wash
distil
water
incub
autofluor
nation
diagnost
min
dri
expos
film
temperatur
block
experi
chase
carri
indic
temperatur
individu
water
bath
purifi
viru
pg
digest
unit
peptid
aiglycosidas
f
pngf
gift
dr
j
elder
scripp
clinic
research
foundat
vari
length
time
remov
nlink
carbohydr
sampl
separ
sdspage
electrophoret
transfer
nitrocellulos
immunoblot
mab
specif
either
virusinfect
uninfect
control
monolay
cultur
cell
detach
scrape
rubber
policeman
pellet
g
pellet
fix
buffer
glutaraldehyd
epon
embed
thin
section
prepar
stain
osmium
tetroxid
examin
hitachi
electron
microscop
purifi
lcmv
digest
pngf
describ
materi
method
sampl
digest
remov
immedi
ad
reagent
time
hr
indic
polypeptid
resolv
sdspage
gel
viral
protein
visual
western
blot
use
specif
mab
mab
mab
previous
observ
precursor
molecul
gpc
label
heavili
mannos
wherea
matur
glycoprotein
contain
rel
littl
mannos
label
galactos
fucos
buchmeier
oldston
result
suggest
gpc
contain
high
mannos
oligosaccharid
trim
complex
form
prior
posttransl
proteolyt
cleavag
order
determin
extent
glycosyl
glycoprotein
purifi
viru
digest
pngf
variou
interv
separ
sdspage
western
blot
gplor
antisera
digest
produc
ladder
band
repres
polypeptid
chain
success
fewer
oligosaccharid
side
chain
method
abl
demonstr
total
six
band
react
antibodi
indic
contain
five
nlink
carbohydr
fig
one
band
label
fig
present
momentarili
addit
pngf
comigr
fastest
migrat
portion
undigest
band
suggest
nativ
may
actual
mixtur
polypeptid
core
chain
four
five
oligosaccharid
durat
synthesi
cleavag
gpc
order
estim
time
synthesi
cleavag
gpc
replic
cultur
puls
min
met
chase
interv
min
immunoprecipit
antibodi
result
pulsechas
experi
illustr
fig
gpc
evid
immedi
puls
indic
gpc
cleavag
evid
min
chase
elaps
addit
experi
focus
chase
interv
observ
first
appear
min
data
shown
posttransl
cleavag
gpc
requir
prior
glycosyl
experi
carri
character
two
neutral
epitop
found
fold
gpc
precursor
requir
nlink
glycosyl
wright
et
order
investig
role
glycosyl
posttransl
process
util
glycosyl
inhibitor
tun
dmj
ssn
csp
nmdnj
examin
requir
nlink
glycosyl
detail
cell
infect
incub
indic
inhibitor
hr
prior
puls
label
hr
methionin
label
cell
chase
presenc
drug
hr
immunoprecipit
mab
presenc
tun
slight
reduct
band
repres
unglycosyl
gpc
concomit
appear
faster
migrat
band
indic
unglycosyl
next
examin
effect
inhibit
oligosaccharid
trim
cleavag
use
inhibitor
csp
nmdnj
dmj
ssn
csp
nmdnj
inhibit
glucosidas
ii
prevent
trim
termin
glucos
residu
core
oligosaccharid
dmj
ssn
inhibit
mannosidas
ii
respect
prevent
trim
event
occur
golgi
review
see
elbein
presenc
trim
inhibitor
cleavag
gpc
observ
fig
data
ssn
shown
quantit
estim
proport
incorpor
radioact
gpc
puls
chase
sampl
made
basi
densitomet
scan
expos
film
tabl
summar
analysi
experi
de
data
indic
absenc
glycosyl
cleavag
fail
occur
protein
transport
site
cleavag
perhap
protein
although
transport
fold
conform
appropri
proteolysi
determin
intracellular
locat
gpc
cleavag
examin
tempor
relationship
cleavag
trim
pulsechas
condit
reduc
temperatur
shown
halt
transport
viral
protein
defin
compart
cell
matlin
simon
sarast
kuismanen
sarast
et
balch
keller
copeland
et
protein
exit
rough
endoplasm
reticulum
halt
pregolgi
compart
protein
reach
transgolgi
determin
transit
complex
carbohydr
transport
cell
surfac
infect
cell
puls
hr
chase
hr
lysat
immunoprecipit
mab
determin
whether
cleavag
taken
place
evid
cleavag
either
tabl
temperatur
uncleav
gpc
remain
eh
sensit
indic
gpc
reach
medial
golgi
defin
locat
precis
repeat
experi
chase
order
find
lowest
temperatur
gpc
acquir
eh
resist
occur
evid
fig
small
amount
present
cell
chase
like
due
cleavag
gpc
puls
period
band
increas
markedli
puls
gpc
sensit
eh
indic
shift
migrat
rel
control
lane
howev
gpc
eh
resist
indic
addit
termin
sugar
temperatur
resist
eh
result
indic
cleavag
gpc
must
occur
trim
medial
transgolgi
later
although
cleavag
occur
portion
gpc
still
eh
sensit
indic
transport
past
medial
golgi
compart
incomplet
temperatur
fulllength
gpc
acquir
eh
resist
suggest
cleavag
essenti
transport
gpc
medial
golgi
result
experi
indic
gpc
cleav
medial
transgolgi
later
absenc
nlink
glycosyl
gpc
cleav
seem
like
unglycosyl
protein
transport
site
cleavag
could
exclud
possibl
abnorm
fold
preclud
recognit
distribut
label
gpc
estim
quantit
densitometri
two
autoradiograph
exposur
gel
shown
fig
total
area
gpc
band
normal
percentag
distribut
exposur
peak
shown
puls
label
hr
methionin
pciml
metfre
medium
c
chase
hr
presenc
ofold
excess
unlabel
methionin
present
unglycosyl
gpc
distribut
label
gpc
estim
quantit
densitometri
two
autoradiograph
exposur
gel
shown
fig
total
area
gpc
band
normal
percentag
distribut
exposur
peak
shown
data
pool
two
experi
puls
label
hr
rciml
methronin
metfre
medium
c
chase
period
hr
indic
temperatur
ofold
excess
methionin
appropri
proteas
anoth
measur
effect
glycosyl
inhibitor
transport
assay
product
infecti
viru
grown
presenc
tun
ssn
csp
supern
infect
cell
titer
hr
infect
medium
contain
drug
chang
hr
data
repres
viru
releas
last
hr
infect
tun
significantli
reduc
amount
viru
produc
fig
determin
whether
reduct
infect
due
product
noninfecti
particl
failur
bud
attempt
purifi
viru
particl
infect
cultur
grown
tun
unabl
band
viru
renograffin
gradient
prepar
supernat
tuntreat
cultur
also
examin
viru
bud
electron
microscopi
found
bud
inhibit
presenc
tun
suggest
unglycosyl
viral
protein
reach
surfac
cell
fig
result
confirm
immunofluoresc
stain
viral
protein
surfac
infect
bhk
cell
use
mab
stain
control
virusinfect
cell
also
react
unglycosyl
glycoprotein
permeabil
cell
treat
tun
mab
fail
detect
viral
protein
surfac
tuntreat
cell
fig
viral
glycoprotein
evid
surfac
infect
cell
treat
trim
inhibitor
csp
ssn
agreement
infect
data
thu
conclud
studi
transport
unglycosyl
protein
cell
surfac
block
result
present
paper
address
basic
aspect
glycosyl
proteolyt
cleavag
lcmv
glycoprotein
precursor
gpc
process
affect
transport
viral
protein
within
infect
cell
shown
matur
structur
glycoprotein
strain
lcmv
bear
five
two
nlink
complex
carbohi
previou
studi
shown
radiolabel
mannos
glucosamin
preferenti
incorpor
gpc
cleavag
product
label
glucosamin
galactos
fucos
contain
littl
residu
mannos
suggest
gpc
high
mannos
precursor
buchmeier
oldston
role
glycosyl
posttransl
event
examin
found
appropri
fold
glycoprotein
indic
use
mab
bind
conform
epitop
fail
occur
without
glycosyl
wright
et
al
present
studi
demonstr
cleavag
transport
gpc
also
fail
occur
glycosyl
block
tun
determin
prevent
glycosyl
affect
cleavag
need
establish
tempor
sequenc
oligosaccharid
trim
proteolyt
cleavag
gpc
note
bear
complex
carbohydr
gpc
contain
predominantli
mannoserich
core
sugar
quantit
minor
fraction
gpc
howev
contain
fucos
galactos
indic
matur
nlink
oligosaccharid
transit
high
mannos
carbohydr
complex
carbohydr
measur
loss
sensit
eh
acquisit
termin
sugar
occur
medial
golgi
balch
keller
result
pulsechas
experi
suggest
cleavag
occur
approxim
min
synthesi
transport
medial
golgi
conclus
strengthen
temperatur
block
pulsechas
experi
infect
cell
incub
temperatur
known
halt
protein
transport
defin
compart
within
cell
never
observ
eh
sensit
cleav
molecul
indic
transit
complex
carbohydr
occur
cleavag
moreov
temperatur
block
experi
local
site
cleavag
golgi
apparatu
cell
puls
chase
cleavag
gpc
observ
chase
perform
temperatur
halt
transport
medialtransgolgi
observ
cleavag
similar
seen
cell
chase
report
site
cleavag
precursor
glycoprotein
envelop
rna
virus
vari
respect
lcmv
resembl
close
paramyxovirus
f
protein
cleav
transgolgi
immedi
transgolgi
compart
sato
et
yamada
et
morrison
et
nagai
et
howev
measl
viru
unlik
lcmv
cleavag
appar
continu
cell
surfac
yamada
et
al
two
like
possibl
explain
prevent
glycosyl
interfer
cleavag
gpc
either
unglycosyl
gpc
polypeptid
chain
aggreg
rer
reach
site
cleavag
cleavag
depend
conform
express
unglycosyl
molecul
result
indic
condit
tun
block
unglycosyl
uncleav
gpc
reach
ceil
surfac
prevent
gpc
transport
reflect
lack
viral
glycoprotein
stain
cell
surfac
failur
produc
virion
bud
plasma
membran
similar
find
report
felin
murin
leukemia
viru
polinoff
et
al
pinter
et
masonpf
monkey
viru
chatterje
et
al
junin
viru
padula
de
martinez
segovia
bovin
herp
viru
van
grunenlittelvan
den
hurk
babiuk
vesicular
stomat
viru
vsv
leavitt
et
latter
suggest
failur
transport
due
protein
aggreg
rer
gibson
et
al
gibson
et
al
unglycosyl
envelop
protein
measl
viru
sato
eta
sendai
viru
mottet
et
al
also
may
remain
rer
observ
accumul
unglycosyl
gpc
within
cell
form
recogn
antibodi
conform
epitop
gpc
wright
et
al
attempt
demonstr
transport
unglycosyl
gpc
cell
held
condit
unglycosyl
vsv
g
protein
transport
neither
gpc
transport
virion
product
observ
basi
accumul
evid
like
unglycosyl
gpc
aggreg
rer
pregolgi
compart
thu
never
reach
site
proteolysi
determin
whether
transport
cleavag
depend
upon
oligosaccharid
chain
structur
assess
cleavag
presenc
varieti
inhibitor
oligosaccharid
trim
virus
addit
core
oligosaccharid
alon
adequ
transport
addit
trim
sugar
moieti
requir
specif
prevent
trim
outermost
glucos
moieti
core
oligosaccharid
glc
man
glcnac
either
csp
dnj
inhibit
transport
envelop
glycoprotein
murin
retrovirus
pinter
et
murin
hepatitisviru
repp
eta
vsv
schlesing
et
effect
transport
ha
influenza
romero
et
burk
et
elbein
et
al
envelop
glycoprotein
rsv
bosch
schwarz
drug
reduc
infect
sindbi
prevent
transport
prevent
cleavag
glycoprotein
precursor
schlesing
et
mcdowel
et
lcmv
found
addit
core
oligosaccharid
alon
without
process
suffici
allow
transport
cleavag
product
infecti
particl
although
correl
absenc
cleavag
reduc
infect
experi
know
whether
cleavag
necessari
transport
plasma
membran
occasion
see
small
amount
glycoprotein
comigr
gpc
associ
matur
virion
other
report
molecul
size
gpc
surfac
infect
cell
van
der
zeijst
eta
suggest
cleavag
may
absolut
requir
viral
matur
rel
experi
conduct
viral
system
need
cleavag
examin
absenc
drug
tun
monensin
also
effect
transport
cleavag
glycoprotein
precursor
activ
fusion
activ
subunit
case
mani
envelop
rna
virus
absenc
cleavag
would
reduc
infect
true
sendai
viru
choppin
mammalian
influenza
virus
grown
avian
cell
klenk
er
al
lazarowitz
choppin
kawaoka
et
al
mccune
eta
heretofor
glycoprotein
lcmv
associ
membran
fusion
activ
effort
defin
biosynthet
pathway
lcmv
glycoprotein
interact
virion
structur
way
acknowledg
public
depart
immunolog
research
institut
scripp
clinic
la
jolla
california
work
support
nih
grant
fellowship
kew
arthriti
societi
canada
jwb
support
postdoctor
train
grant
thank
rebecca
day
mari
pain
excel
technic
assist
jim
johnston
manuscript
prepar
john
elder
john
harper
help
comment
